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A B S T R A C T 
The relationship between Q T interval dispersion and dipyridamole-induced, transient myocardial ischemia 
was assessed in 32 male patients with ischemic heart disease. A standardized, high dose dipyridamole-ECG 
stress test was used as dipyridamole infusion of 0,56 mg/kg applied i. v. for 4 min followed by 4 min interval of 
no-dose with E C G and blood pressure monitoring, and in negative test - by a dipyridamole infusion of 
0,28mg/kg i. v. for 2 min. Seventeen patients (53%) developed a transient myocardial ischemia with duration 
of 20 ±7 (4-40) min during the dipyridamole infusion while 15 ones (47%) did not. No regular dynamics and 
significant differences in the values of total Q T interval dispersion and maximum adjacent Q T interval dis­
persion estimated before, during and after the dipyridamole infusion could be established. It was supposed 
that the severity, duration and time for development of dipyridamole-induced transient myocardial ischemia 
were not sufficient to generate a dispersion in ventricular repolarization detectable as changes in Q T disper­
sion parameters on surface E C G . The combination of Q T dispersion with various non-invasive markers of 
arrhythmogenic mechanisms could help the estimation of arrhythmogenic risk in the patients with ischemic 
heart disease. 
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The assessment of the QT interval dispersion (QTd) is a 
simplified, cheap and non-invasive method for determina-
tion of the homogeneity of ventricular repolarization. It is 
known that any dispersion of repolarisation exists even in 
the normal heart (1). 
QTd increases in the early hours of acute myocardial infarc­
tion (Ml) and falls with time (1). There are data for reduc­
tion of QTd in patients taking sotalol after Ml (3), as well as 
after successful thrombolysis (4,5). 
In patients with a long QT interval the values of QTd may 
help to identify subjects prone to dangerous ventricular 
arrhythmias (2). 
It is obvious that QTd has a dynamic nature and can be in­
fluenced by a variety of factors. We hypothesized that since 
QT interval changes are dynamic in nature, there possibly 
could be found any relationship between QTd and myocar­
dial ischemia 
The aim of the study was to assess whether there is a rela­
tion between QTd calculated from the conventional ECG 
and the transient myocardial ischemia (TMI) induced by 
Dipyridamole infusion (DI) in patients with ischemic heart 
disease (1HD). 
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M A T E R I A L AND M E T H O D S 
Thirty-two males with IHD, 55 ±9 (42-70) years old, 27 
with AMI , 2 with previous MI, 2 with angina pectoris and 1 
with silent IHD, were evaluated. Each patient underwent 
standard high dose Dipyridamole-ECG stress test: "low" 
dose of 0,56mg/kg Dipyridamole i.v. for 4 min, followed of 
4 min. interval of no-dose with ECG and blood pressure 
monitoring, and in case of a negative test - "high" dose 
Dipyridamole, 0,28mg/kg i.v. for 2min. Dipyridamole ef­
fects were terminated by Aminophylline 240mg i.v. (7). 
Antiischemic therapy was discontinued at least 12 hours 
before the test. Twelve-lead E C G (Hellige E K 512 P) was 
registered before, during and after DI . The QT interval was 
measured manually, with calipers, in all 12 leads from the 
onset of QRS to the end of the T wave. 
The end of the T wave was defined as the point of return to 
the TP baseline or the nadir between the T and U waves, 
when U wave was present (6). The corrected QT interval 
(QTc) was calculated using Bazett's formula. For each lead 
three consecutive cycles were measured and an average 
QTd was calculated. 
The total QTd dispersion (TQTcd) was defined as the dif­
ference between the maximum and the minimum QTd oc­
curring in any of the 12 leads (6). The maximum adjacent 
QTd dispersion (MAQTcd) was defined as the maximum 
QTd difference between two adjacent precordial leads 
(8,9). All measurements were performed by one and the 
39 
Y . Peychev, A. Angelov, Y . Yotov . 
Table 1. TQTcd in patients with induced TMI (group 1, n= 17) 
Index before Dl during Dl after Dl Pi p2 
TQTcd (ms) 53.4 ± 18,6 53,6 ±20,3 50,8 ± 20,2 NS NS 
MAQTcd (ms) 30,2 ± 11,3 27,6 ± 16,9 29,7 ± 12,0 NS NS 
p 1 - before vs during Dl p2 - before vs after Dl 
?. TQTcd in patients without induced TMI (group 2, n = 15) 
Index before Dl during Dl after Dl pl P2 
TQTcd (ms) 48,0 ± 18,8 513 ± 17,3 50,5 ± 11,9 NS NS 
MAQTcd (ms) 27,4 ± 15,7 28,7 ± 16,5 26,9 ± 15,3 NS NS 
p 1 - before vs during Dl p2 - before vs after Dl 
Table 3. TQTcd and dipyridamole-induced myocardial ischemia 
TQTcd (ms) TMI+ TMI- P 
before Dl 54,3 ± 18,6 48,0 ± 18,8 NS 
during Dl 53,6 ±20,3 51,3 ± 17,3 NS 
after Dl 50,8 ± 20,2 
_ . , .... __ . , 
50,5 ± 11,9 NS 
Table 4. MAQTcd and dipyridamole-induced myocardial ischemia 
MAQTcd (ms) TMI+ TMI- P 
before Dl 30Д± 11,3 27,4 ± 15,7 NS 
during Dl 27,6 ± 16,9 28,7 ± 16,5 NS 
after Dl 29,7 ± 12,0 26,9 ± 15,3 NS 
Both TQTcd and MAQTcd before, during and after Dl 
show no significant differences when compared between 
group 1 (TMI+) and group 2 (TMI-) (Table 3 and Table 4). 
No dangerous ventricular arrhythmias occurred during Dl 
in any patient from both groups. 
The relationship between QTd and myocardial ischemia is 
not investigated thoroughly. According to our results 
Dipyridamole-induced myocardial ischemia does not lead 
to any significant changes in the indices of QT dispersion as 
well as to dangerous ventricular arrhythmias. 
Possibly, the QT interval and its related indices calculated 
from the surface ECG reflect integrally different aspects of 
cardiac electrophysiology (cell groups and zones with delay 
same observer in order to eliminate the interobserver mis­
take. We accepted 20-50 ms as a normal rate-corrected 
value for QT dispersion (6). 
R E S U L T S AND D I S C U S S I O N 
Seventeen patients (53%) (group 1) developed TMI with 
duration 20 ±7 (4-40) min. during Dl, whereas 15 patients 
(47%) (group 2) did not. We found no regular dynamics 
and no significant differences in the values of TQTcd and 
MAQTcd estimated before, during and after Dl within each 
of the groups. The results are presented in Table 1 and Ta­
ble 2. 
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repolarisation), cardiac geometry (regional wall motion 
normalities or asymmetric hypertrophy), tissue imped-
ce, shape of thorax and neurohormonal factors (auto-
mic tone, serum electrolytes). The acute myocardial 
hernia, which probably does influence ventricular depo-
ization and repolarization and arrhythmogenesis, respec-
ely, can not be separated from the above factors. So 
hen we interpret possible changes in QTd during experi-
ental myocardial ischemia one should keep in mind this 
-t. 
urthermore the question of how the severity, duration and 
me for development of TMI reflect the changes of QTd 
eters remains open. 
C O N C L U S I O N 
hort-lasting TMI does not lead to significant changes in 
Td parameters. Probably, the severity, duration and the 
'me for development of Dipyridamole-induced TMI are 
ot sufficient to generate a dispersion in ventricular 
polarization that could be detected as changes in QT dis-
rsion parameters on the surface E C G . 
е combination of QTd with various non-invasive mark-
rs of arrhythmogenic mechanisms could help the estima-
on of arrhythmogenic risk in the patients with IHD. 
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